Gul Balwani is a notable inventor based in West Windsor, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the efficacy of azelastine. With a total of 6 patents to his name, Balwani's work has the potential to improve the quality of life for many patients suffering from various disorders.

Latest Patents

Balwani's latest patents focus on pharmaceutical compositions comprising azelastine, or its pharmaceutically acceptable salts or esters, including azelastine hydrochloride. These compositions are designed to include additional active agents and are formulated with carriers or excipients that help reduce post-nasal drip and mask the unpleasant bitter taste associated with such treatments. The effective excipients identified in his inventions include hypromellose as a viscosity modifier and sucralose as a taste-masking agent. His inventions also provide methods for treating or preventing disorders such as allergic rhinitis, non-allergic vasomotor rhinitis, and allergic conjunctivitis, offering symptomatic relief to patients.

Career Highlights

Gul Balwani is currently associated with Meda Pharmaceuticals Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to improving patient outcomes through effective medication formulations.

Collaborations

Some of his notable coworkers include Alexander D D'Addio and Phuong Grace Dang, who contribute to the collaborative environment that fosters innovation at Meda Pharmaceuticals Inc.

Conclusion

Gul Balwani's contributions to pharmaceutical innovations, particularly in the formulation of azelastine compositions, highlight his role as a significant inventor in the industry. His work not only advances medical science but also aims to enhance patient care through effective treatment options.

This text is generated by artificial intelligence and may not be accurate.